Acta Neuropathologica

, Volume 107, Issue 4, pp 331–335 | Cite as

Age-related axonal and myelin changes in the rumpshaker mutation of the Plp gene

  • J. M. Edgar
  • M. McLaughlin
  • J. A. Barrie
  • M. C. McCulloch
  • J. Garbern
  • I. R. GriffithsEmail author
Regular Paper


The PLP1/Plp gene encodes proteolipid protein (PLP) and DM20, the major central nervous system myelin proteins. Mutations in the PLP1/Plp gene cause dysmyelinating disorders in man and animals. The rumpshaker mutation was first identified in mice and later linked to a family diagnosed with neurological deficits akin to spastic paraplegia. The dysmyelination in the young rumpshaker mouse is well characterised. Here we report evidence for an age-related increase in myelin due mainly to the myelination of small axons, many large axons remain dysmyelinated. Levels of PLP/DM20 and myelin basic protein are considerably greater in myelin fractions from older compared with younger mutants. Myelin in sheaths of larger axons remains poorly compacted and may account for levels of 2’,3’-cyclic nucleotide 3’-phosphodiesterase and myelin-associated glycoprotein being elevated over wild type in older mutant mice. A late-onset distal degeneration of the axons of the longest spinal tract, the fasciculus gracilis, is also noted. This is the first report of Wallerian-type degeneration in mice with spontaneous mutations of the Plp gene.


Wallerian degeneration Proteolipid protein Myelin proteins Dysmyelination 



This study was funded by the Wellcome Trust and The National Multiple Sclerosis Society (RG 3204A1).


  1. 1.
    Al-Saktawi K, McLaughlin M, Klugmann M, Schneider A, Barrie JA, McCulloch MC, Montague P, Kirkham D, Nave K-A, Griffiths IR (2003) Genetic background determines phenotypic severity of the Plp rumpshaker mutation. J Neurosci Res 72:12–24CrossRefPubMedGoogle Scholar
  2. 2.
    Bizzozero OA, Bixler HA, Davis JD, Espinosa A, Messier AM (2001) Chemical deacylation reduces the adhesive properties of proteolipid protein and leads to decompaction of the myelin sheath. J Neurochem 76:1129–1141CrossRefPubMedGoogle Scholar
  3. 3.
    Blakemore WF (1982) Myelination, demyelination and remyelination in the CNS. In: Cavanagh JB (ed) Recent Advances in Neuropathology, vol 2. Churchill Livingstone, Edinburgh, pp 53–81Google Scholar
  4. 4.
    Dentinger MP, Barron KD, Csiza CK (1982) Ultrastructure of the central nervous system in a myelin deficient rat. J Neurocytol 11:671–691PubMedGoogle Scholar
  5. 5.
    Fanarraga ML, Griffiths IR, McCulloch MC, Barrie JA, Kennedy PGE, Brophy PJ (1992) Rumpshaker: an X-linked mutation causing hypomyelination. Developmental differences in myelination and glial cells between the optic nerve and spinal cord. Glia 5:161–170PubMedGoogle Scholar
  6. 6.
    Garbern J, Yool DA, Moore GJ, Wilds I, Faulk M, Klugmann M, Nave K-A, Sistermans EA, Knaap MS van der, Bird TD, Shy ME, Kamholz J, Griffiths IR (2002) Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125:551–561CrossRefPubMedGoogle Scholar
  7. 7.
    Ginter DN, Konigsmark BA, Abbott MH (1974) X-linked spinocerebellar degeneration. Birth Defects Orig Art Ser X4:334–336Google Scholar
  8. 8.
    Griffiths IR, Duncan ID, McCulloch M (1981) Shaking pup: a disorder of central myelination in the spaniel dog. II. Ultrastructural observations on the white matter of cervical spinal cord. J Neurocytol 10:847–858PubMedGoogle Scholar
  9. 9.
    Griffiths IR, Scott I, McCulloch MC, Barrie JA, McPhilemy K, Cattanach BM (1990) Rumpshaker mouse: a new X-linked mutation affecting myelination: evidence for a defect in PLP expression. J Neurocytol 19:273–283PubMedGoogle Scholar
  10. 10.
    Griffiths IR, Klugmann M, Anderson TJ, Yool D, Thomson CE, Schwab MH, Schneider A, Zimmermann F, McCulloch MC, Nadon NL, Nave K-A (1998) Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610–1613PubMedGoogle Scholar
  11. 11.
    Hildebrand C, Remahl S, Persson H, Bjartmar C (1993) Myelinated nerve fibres in the CNS. Prog Neurobiol 40:319–384CrossRefPubMedGoogle Scholar
  12. 12.
    Johnston, AW, McKusick VA (1962) A sex-linked recessive form of spastic paraplegia. Am J Hum Genet 14:83–94PubMedGoogle Scholar
  13. 13.
    Karthigasan J, Evans EL, Vouyiouklis DA, Inouye H, Borenshteyn N, Ramamurthy GV, Kirschner DA (1996) Effects of rumpshaker mutation on CNS myelin composition and structure. J Neurochem 66:338–345PubMedGoogle Scholar
  14. 14.
    Naidu S, Dlouhy SR, Geraghty MT, Hodes ME (1997) A male child with the rumpshaker mutation, X-linked spastic paraplegia Pelizaeus-Merzbacher disease and lysinuria. J Inherit Metab Dis 20:811–816CrossRefPubMedGoogle Scholar
  15. 15.
    Remahl S, Hildebrand C (1990) Relation between axons and oligodendroglial cells during initial myelination. I. The glial unit. J Neurocytol 19:313–328PubMedGoogle Scholar
  16. 16.
    Simons M, Krämer EM, Thiele C, Stoffel W, Trotter J (2000) Assembly of myelin by association of proteolipid protein with cholesterol- and galactosylceramide-rich membrane domains. J Cell Biol 151:143–153CrossRefPubMedGoogle Scholar
  17. 17.
    Taraszewska A (1988) Ultrastructure of axons in disturbed CNS myelination in pt rabbit. Neuropatol Pol 26:387–402Google Scholar
  18. 18.
    Weimbs T, Stoffel W (1992) Proteolipid protein (PLP) of CNS myelin: positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP. Biochemistry 31:12289–12296PubMedGoogle Scholar
  19. 19.
    Yool DA, Klugmann M, McLaughlin M, Vouyiouklis DA, Dimou L, Barrie JA, McCulloch MC, Nave K-A, Griffiths IR (2001) Myelin proteolipid proteins promote the interaction of oligodendrocytes and axons. J Neurosci Res 63:151–164CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • J. M. Edgar
    • 1
  • M. McLaughlin
    • 1
  • J. A. Barrie
    • 1
  • M. C. McCulloch
    • 1
  • J. Garbern
    • 2
  • I. R. Griffiths
    • 1
    Email author
  1. 1.Applied Neurobiology Group, Department of Veterinary Clinical Studies, Institute of Comparative MedicineUniversity of GlasgowGlasgowScotland
  2. 2.Department of Neurology and Center for Molecular Medicine and GeneticsWayne State UniversityDetroitUSA

Personalised recommendations